Tech Company Financing Transactions
Moma Therapeutics Funding Round
Goldman Sachs, Alexandria Venture Investments and Casdin Capital participated in a $150 million Series B capital raise for Moma Therapeutics. This venture round was announced on 5/10/2022.
Transaction Overview
Company Name
Announced On
5/10/2022
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds to fund the advancement of multiple precision oncology programs toward the clinic
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
215 1st St. 150
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
We're on a mission to unlock molecular machines by understanding and respecting their complexities. We'll be working incredibly hard to discover their untapped potential because we believe they are the key to delivering the next generation of precision medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reid Huber
Chief Operating Officer
Walt Kowtoniuk
Chief Scientific Officer
Christoph Lengauer
Vice President
Timothy Guzi
VP - Product Management
Sarah Larson
Browse more venture capital transactions:
Prev: 5/10/2022: Abnormal Security venture capital transaction
Next: 5/10/2022: Domain Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs